The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Growth in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant increase in short interest in June. As of June 15th, there was short interest totalling 13,000 shares, an increase of 94.0% from the May 31st total of 6,700 shares. Based on an average daily trading volume, of 24,900 shares, the days-to-cover ratio is currently 0.5 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Price Performance

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.08 during midday trading on Friday, hitting $18.20. 8,036 shares of the company’s stock were exchanged, compared to its average volume of 22,491. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52-week low of $15.60 and a 52-week high of $20.75. The stock has a 50-day moving average price of $18.17 and a two-hundred day moving average price of $19.16.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Wednesday, May 1st were given a dividend of $0.2891 per share. This represents a $1.16 annualized dividend and a yield of 6.35%. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date was Tuesday, April 30th.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.